Covalent Bond between Ligand and Receptor Required for Efficient Activation in Rhodopsin

被引:16
|
作者
Matsuyama, Take
Yamashita, Takahiro
Imai, Hiroo [1 ]
Shichida, Yoshinori
机构
[1] Kyoto Univ, Primates Res Inst, Dept Mol Cell Biol, Aichi 4848506, Japan
关键词
RETINAL SCHIFF-BASE; METARHODOPSIN-II; VISUAL PIGMENTS; CHROMOPHORE CONFIGURATION; CONSTITUTIVE ACTIVATION; COMPLEX-FORMATION; BOVINE RHODOPSIN; 1ST STEP; BINDING; PROTEIN;
D O I
10.1074/jbc.M109.063875
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rhodopsin is an extensively studied member of the G-protein coupled receptors (GPCRs). Although rhodopsin shares many features with the other GPCRs, it exhibits unique features as a photoreceptor molecule. A hallmark in the molecular structure of rhodopsin is the covalently bound chromophore that regulates the activity of the receptor acting as an agonist or inverse agonist. Here we show the pivotal role of the covalent bond between the retinal chromophore and the lysine residue at position 296 in the activation pathway of bovine rhodopsin, by use of a rhodopsin mutant K296G reconstituted with retinylidene Schiff bases. Our results show that photoreceptive functions of rhodopsin, such as regiospecific photoisomerization of the ligand, and its quantum yield were not affected by the absence of the covalent bond, whereas the activation mechanism triggered by photoisomerization of the retinal was severely affected. Furthermore, our results show that an active state similar to the Meta-II intermediate of wild-type rhodopsin did not form in the bleaching process of this mutant, although it exhibited relatively weak G protein activity after light irradiation because of an increased basal activity of the receptor. We propose that the covalent bond is required for transmitting structural changes from the photoisomerized agonist to the receptor and that the covalent bond forcibly keeps the low affinity agonist in the receptor, resulting in a more efficient G protein activation.
引用
收藏
页码:8114 / 8121
页数:8
相关论文
共 50 条
  • [1] A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor
    Bledsoe, RK
    Madauss, KP
    Holt, JA
    Apolito, CJ
    Lambert, MH
    Pearce, KH
    Stanley, TB
    Stewart, EL
    Trump, RP
    Willson, TM
    Williams, SP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (35) : 31283 - 31293
  • [2] TRANSDUCIN ACTIVATION BY RHODOPSIN WITHOUT A COVALENT BOND TO THE 11-CIS-RETINAL CHROMOPHORE
    ZHUKOVSKY, EA
    ROBINSON, PR
    OPRIAN, DD
    SCIENCE, 1991, 251 (4993) : 558 - 560
  • [3] Estrogen receptor residues required for stereospecific ligand recognition and activation
    Bocchinfuso, WP
    Korach, KS
    MOLECULAR ENDOCRINOLOGY, 1997, 11 (05) : 587 - 594
  • [4] A disulfide bond between conserved cysteines in the extracellular loops of the human VIP receptor is required for binding and activation
    Knudsen, SM
    Tams, JW
    Wulff, BS
    Fahrenkrug, J
    FEBS LETTERS, 1997, 412 (01) : 141 - 143
  • [5] Mechanism of Activation of the Visual Receptor Rhodopsin
    Smith, Steven O.
    ANNUAL REVIEW OF BIOPHYSICS, 2023, 52 : 301 - 317
  • [6] No ligand binding in the GB2 subunit of the GABAB receptor is required for activation and allosteric interaction between the subunits
    Kniazeff, J
    Galvez, T
    Labesse, G
    Pin, JP
    JOURNAL OF NEUROSCIENCE, 2002, 22 (17): : 7352 - 7361
  • [7] Between a hydrogen and a covalent bond
    Bonn, Mischa
    Hunger, Johannes
    SCIENCE, 2021, 371 (6525) : 123 - +
  • [8] The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction
    Hoyer-Hansen, G
    Behrendt, N
    Ploug, M
    Dano, K
    Preissner, KT
    FEBS LETTERS, 1997, 420 (01) : 79 - 85
  • [9] Insights into the activation mechanism of the visual receptor rhodopsin
    Smith, Steven O.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 389 - 393
  • [10] LIGAND OCCUPANCY IS NOT REQUIRED FOR VITAMIN-D-RECEPTOR AND RETINOID RECEPTOR-MEDIATED TRANSCRIPTIONAL ACTIVATION
    MATKOVITS, T
    CHRISTAKOS, S
    MOLECULAR ENDOCRINOLOGY, 1995, 9 (02) : 232 - 242